0 Comentários
0 Compartilhamentos
264 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
- Faça Login para curtir, compartilhar e comentar!
- Retinal Biologics Market Share Trends: Future Growth and OpportunitiesThe global Retinal Biologics Market Share was valued at USD 22.5 billion in 2023 and is expected to reach USD 49.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.2% during the forecast period from 2024 to 2032. The market's growth is propelled by the increasing prevalence of retinal disorders, such as age-related macular degeneration (AMD) and diabetic retinopathy,...0 Comentários 0 Compartilhamentos 226 Visualizações 0 Anterior
- The Future of the Retinal Biologics Market Size: Trends to WatchThe Retinal Biologics Market Segment, valued at USD 22.5 billion in 2023, is projected to expand to USD 49.5 billion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period from 2024 to 2032. Retinal biologics are innovative therapeutic agents used to treat various retinal disorders, including age-related macular degeneration (AMD), diabetic retinopathy, and...0 Comentários 0 Compartilhamentos 250 Visualizações 0 Anterior
- The Retinal Biologics Market in 2024: Trends and PredictionsThe global Retinal Biologics Market was valued at USD 22.5 billion in 2023 and is expected to reach USD 49.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.2% during the forecast period from 2024 to 2032. The market's growth is propelled by the increasing prevalence of retinal disorders, such as age-related macular degeneration (AMD) and diabetic retinopathy, alongside...0 Comentários 0 Compartilhamentos 343 Visualizações 0 Anterior
- The Retinal Biologics Market in 2024: Trends and PredictionsThe global Retinal Biologics Market was valued at USD 22.5 billion in 2023 and is expected to reach USD 49.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.2% during the forecast period from 2024 to 2032. The market's growth is propelled by the increasing prevalence of retinal disorders, such as age-related macular degeneration (AMD) and diabetic retinopathy, alongside...0 Comentários 0 Compartilhamentos 307 Visualizações 0 Anterior